Pheenom I appreciate the efforts you go to on posting on this stock but I am a little curious as to how under continious disclosure rules that positive trial results shouldn't be reported and why if there are deals afoot then dr gray wouldn't want the sp too be much higher than it is now as a basis for negotiations and it would be if the company released the trial results to the market.
genentech inc., page-3
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)